Head Lice Infestation
📧 Sign up to get email alerts when something new happens for Head Lice Infestation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Efficacy and Safetyof a Medical Device With a Physical Mode of Action (X92001919) Versus Paranix Anti-lice Shampoo. [NA]
Clinical trial comparing a medical device with physical action (X92001919) to Paranix Anti-lice Shampoo for head lice, currently not yet rec…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation [Phase 4]
A Phase 4 study evaluating the efficacy and safety of a leave-in spray for head lice infestation (Pediculosis capitis) has completed with re…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation [Phase 2]
Phase 2 trial evaluating ovicidal efficacy and safety of abametapir 0.74% lotion for treating head lice infestation has completed with poste…
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation [Phase 3]
Phase 3 study evaluating the efficacy and safety of abametapir lotion for treating head lice infestation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of abametapir lotion for treating head lice infestation and has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation [Phase 2]
Phase 2 pediatric safety and pharmacokinetics study of Ha44 Gel for treating head lice infestation has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5% [Phase 1]
This updates the completion of a Phase 1 bioequivalence study comparing two formulations of ivermectin lotion 0.5% for head lice infestation…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: A Pilot Dose Ranging Study of Spinosad Creme Rinse [Phase 2]
A Phase 2 pilot dose-ranging study evaluating Spinosad Creme Rinse for pediculosis capitis (head lice) has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Cocamide DEA vs Permethrin for Head Lice [Phase 3]
Phase 3 trial comparing cocamide DEA to permethrin for head lice (Pediculosis Capitis / Head Lice Infestation) was terminated.
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Two Treatment Regimens of Cocamide DEA Lotion for Head Lice [Phase 2, Phase 3]
Clinical trial update for Cocamide DEA Lotion in Phase 2 and Phase 3 for head lice (pediculosis) has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation [Phase 2]
Phase 2 safety and pharmacokinetic study of Ha44 Gel under maximal use conditions for head lice infestation has completed with results poste…
-
FDA approval · 2014-12-30FDA Approved: NATROBA — Supplemental Application (Cipher Pharmaceuticals Inc.)
The FDA approved a supplemental application for NATROBA (spinosad) filed by Cipher Pharmaceuticals Inc., updating the labeling for the exist…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice [Phase 2, Phase 3]
A clinical trial update reports on safety and tolerability of a novel malathion formulation in children aged 6-24 months with head lice (ped…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of a novel malathion formulation for treating head lice has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice [Phase 2]
Phase 2 trial evaluating safety and tolerability of a novel malathion formulation for head lice in infants and toddlers; the study was termi…
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation [Phase 2]
A Phase 2 dose-ranging trial evaluating an ivermectin-based treatment conditioner for head lice infestation has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2010-12-28Clinical Trial Update: A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation [Phase 2]
Phase 2 trial evaluating safety and efficacy of BGC20-0582 Lice Treatment Gel for head lice infestation has completed with results posted.
-
FDA approval · 2010-09-30FDA Approved: GOOD SENSE LICE KILLING CREME RINSE — Supplemental Application (L. Perrigo Company)
FDA approved a supplemental application for Good Sense Lice Killing Creme Rinse (permethrin) from L. Perrigo Company in connection with its …
-
CLINICAL_TRIALS trial_result · 2009-10-27Clinical Trial Update: Randomized Controlled Trial Comparing Efficacy and Tolerance of Four Pediculicides [NA]
This randomized controlled trial compared the efficacy and tolerability of four pediculicides for head lice infestation.
-
CLINICAL_TRIALS trial_result · 2008-08-04Clinical Trial Update: NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers [Phase 1]
Phase 1 safety study of NatrOVA Creme Rinse conducted in healthy volunteers. The study assesses potential photoallergy risk associated with …